{"content":"<li class=\"n-box-item date-title\" data-end=\"1562212799\" data-start=\"1562126400\" data-txt=\"Monday, December 23, 2019\">Wednesday, July  3, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3475775\" data-ts=\"1562181235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KPTI\" target=\"_blank\">KPTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475775-karyopharm-prices-xpovio-22k-per-month\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Karyopharm prices Xpovio at $22K per month</a></h4><ul><li>During its conference call this afternoon, Karyopharm Therapeutics (<a href='https://seekingalpha.com/symbol/KPTI' title='Karyopharm Therapeutics Inc.'>KPTI</a> <font color=\"green\">+37.3%</font>) stated that the wholesale &#40;WAC&#41; price of XPOVIO (selinexor) will be $22K per month.</li><li>The multiple myeloma med will be distributed through specialty pharmacies, including units of AmerisourceBergen and McKesson.</li><li>The company's marketing application in Europe is currently under EMA review. Management expects conditional approval by year-end.</li><li>Applications in diffuse large B-cell lymphoma are next up.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475775\" data-linked=\"Karyopharm prices Xpovio at $22K per month\" data-tweet=\"$KPTI - Karyopharm prices Xpovio at $22K per month https://seekingalpha.com/news/3475775-karyopharm-prices-xpovio-22k-per-month?source=tweet\" data-url=\"https://seekingalpha.com/news/3475775-karyopharm-prices-xpovio-22k-per-month\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475763\" data-ts=\"1562177429\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475763-grpn-and-sina-among-after-hours-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GRPN and SINA among after hours movers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/BRFS' title='BRF S.A.'>BRFS</a> <font color=\"green\">+1.3%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/SRCI' title='SRC Energy Inc.'>SRCI</a> <font color=\"red\">-2.5%</font>. <a href='https://seekingalpha.com/symbol/CEPU' title='Central Puerto S.A.'>CEPU</a> <font color=\"red\">-2.4%</font>. <a href='https://seekingalpha.com/symbol/GRPN' title='Groupon, Inc.'>GRPN</a> <font color=\"red\">-1.1%. </font><a href='https://seekingalpha.com/symbol/SINA' title='SINA Corporation'>SINA</a> <font color=\"red\">-1.1%</font>. <a href='https://seekingalpha.com/symbol/FWONK' title='Formula One Group'>FWONK</a> <font color=\"red\">-1.0%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475763\" data-linked=\"GRPN and SINA among after hours movers\" data-tweet=\"$BRFS $SRCI $CEPU - GRPN and SINA among after hours movers https://seekingalpha.com/news/3475763-grpn-and-sina-among-after-hours-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3475763-grpn-and-sina-among-after-hours-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475757\" data-ts=\"1562174511\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KPTI\" target=\"_blank\">KPTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475757-karyopharm-chief-commercial-officer-resigns-updated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Karyopharm chief commercial officer resigns (updated)</a></h4><ul>   <li>Karyopharm Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/KPTI' title='Karyopharm Therapeutics Inc.'>KPTI</a>) has disclosed in a filing that its chief commercial officer, Anand Varadan, <a href=\"https://seekingalpha.com/filing/4556917\" target=\"_blank\">resigned from the company</a> effective this Friday, July 5.</li>    <li>It's promoted Perry Monaco to senior VP, Sales, in charge of the sales functions for the company.</li>    <li>In a few minutes, the company's set to <a href=\"https://seekingalpha.com/news/3475727-karyopharm-shares-halted-pending-news-shares-36-percent\" target=\"_blank\">hold a conference call</a> to talk about its selinexor accelerated approval.</li>    <li>Shares closed today's short session <font color=\"green\">up 36%</font>. It's set to resume after-hours trading at 1:35 p.m. following a halt.</li><li><strong>Updated 1:37 p.m.:</strong> Shares have resumed trading, <font color=\"red\">down 2.6%</font> postmarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475757\" data-linked=\"Karyopharm chief commercial officer resigns (updated)\" data-tweet=\"$KPTI - Karyopharm chief commercial officer resigns (updated) https://seekingalpha.com/news/3475757-karyopharm-chief-commercial-officer-resigns-updated?source=tweet\" data-url=\"https://seekingalpha.com/news/3475757-karyopharm-chief-commercial-officer-resigns-updated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475742\" data-ts=\"1562172059\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475742-vodafone-turns-on-5g-network-in-seven-uk-cities\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vodafone turns on 5G network in seven UK cities</a></h4><ul>   <li>Vodafone (<a href=\"http://seekingalpha.com/symbol/VOD\" target=\"_blank\">VOD</a> <font color=\"green\">+2.1%</font>) has <a href=\"https://www.zdnet.com/article/vodafone-switches-on-5g-network-in-the-uk-introduces-new-plans-for-businesses/\" target=\"_blank\">turned on its 5G network</a> in seven UK cities.</li>    <li>That trails rival EE (<a href=\"http://seekingalpha.com/symbol/BT\" target=\"_blank\">BT</a> <font color=\"green\">+1%</font>) by just a month. Notably, though, Vodafone's staying price-aggressive: It won't charge a 5G premium and will bill according to speed rather than data usage.</li>    <li>Vodafone offers three unlimited plans for businesses: Business Unlimited Lite, at £19.16/month ex-VAT; Business Unlimited at £21.66/month; and Business Unlimited Max at £25/month.</li>    <li>Vodafone has launched in seven cities. Along with London, it's on in Birmingham, Bristol, Cardiff, Glasgow, Manchester, and Liverpool. The company plans to add 12 more cities by the end of the year.</li>    <li>It's basing the 5G launch on mid-band spectrum but expects to add low-band airwaves in the 2020-2021 time frame, boosting rural coverage.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475742\" data-linked=\"Vodafone turns on 5G network in seven UK cities\" data-tweet=\"$VOD $BT $VODPF - Vodafone turns on 5G network in seven UK cities https://seekingalpha.com/news/3475742-vodafone-turns-on-5g-network-in-seven-uk-cities?source=tweet\" data-url=\"https://seekingalpha.com/news/3475742-vodafone-turns-on-5g-network-in-seven-uk-cities\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475741\" data-ts=\"1562171875\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBYI\" target=\"_blank\">PBYI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475741-puma-down-3-on-underwhelming-neratinib-data-in-biliary-tract-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Puma down 3% on underwhelming neratinib data in biliary tract cancer</a></h4><ul><li>Puma Biotechnology (<a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a> <font color=\"red\">-2.6%</font>) slips on below-average on the heels of <a href=\"https://seekingalpha.com/pr/17562953-puma-biotechnology-presents-interim-results-biliary-tract-cohort-phase-ii-summit-basket-trial\" target=\"_blank\">preliminary results</a> from a Phase 2 basket study, <a href=\"https://clinicaltrials.gov/ct2/show/NCT01953926?term=puma+biotechnology&amp;rank=3\" target=\"_blank\">SUMMIT</a>, evaluating neratinib in HER2-positive cancers. The data were presented at the ESMO World Congress on Gastrointestinal Cancer in Barcelona.</li><li>Investors appear disappointed with the results from the 20-subject biliary cancer cohort that received neratinib alone. The confirmed objective response rate &#40;ORR&#41; was only 10% (n=2/20), both partials, and the clinical benefit rate (responders + stable cancer) was 30% (n=6/20) (two partial responders + four with stable disease that lasted at least 16 weeks). Median progression-free survival &#40;PFS&#41; was only 1.8 months.</li><li>No new safety signals were observed.</li><li>The estimated primary completion date of the trial is September 2021.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475741\" data-linked=\"Puma down 3% on underwhelming neratinib data in biliary tract cancer\" data-tweet=\"$PBYI - Puma down 3% on underwhelming neratinib data in biliary tract cancer https://seekingalpha.com/news/3475741-puma-down-3-on-underwhelming-neratinib-data-in-biliary-tract-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/3475741-puma-down-3-on-underwhelming-neratinib-data-in-biliary-tract-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475737\" data-ts=\"1562171382\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475737-microcaps-top-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps top tech movers</a></h4><ul><li><strong>Gainers: </strong>One Stop Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/OSS' title='One Stop Systems, Inc.'>OSS</a>) <font color=\"green\">+25%</font>. Symantec Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/SYMC' title='Symantec Corporation'>SYMC</a>) <font color=\"green\">+14%</font>. TuanChe Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/TC' title='TuanChe Limited'>TC</a>) <font color=\"green\">+13%</font>. Pareteum Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) <font color=\"green\">+11%</font>. Mer Telemanagement Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/MTSL' title='Mer Telemanagement Solutions Ltd.'>MTSL</a>) <font color=\"green\">+10%</font>.</li> <li><strong>Losers: </strong>GlobalSCAPE (NYSEMKT:<a href='https://seekingalpha.com/symbol/GSB' title='GlobalSCAPE, Inc.'>GSB</a>) <font color=\"red\">-15%</font>. China Index Holdings Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/CIH' title='China Index Holdings Limited'>CIH</a>) <font color=\"red\">-12%</font>. Pintec Technology Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/PT' title='Pintec Technology Holdings Limited'>PT</a>) <font color=\"red\">-9%</font>. Gravity (NASDAQ:<a href='https://seekingalpha.com/symbol/GRVY' title='Gravity Co., Ltd.'>GRVY</a>) <font color=\"red\">-8%</font>. Phunware (NASDAQ:<a href='https://seekingalpha.com/symbol/PHUN' title='Phunware, Inc.'>PHUN</a>) <font color=\"red\">-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475737\" data-linked=\"Microcaps top tech movers\" data-tweet=\"$OSS $NLOK $TC - Microcaps top tech movers https://seekingalpha.com/news/3475737-microcaps-top-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3475737-microcaps-top-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475736\" data-ts=\"1562171018\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZIOP\" target=\"_blank\">ZIOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475736-ziopharm-up-9-on-nci-researcher-hire\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ziopharm up 9% on NCI researcher hire</a></h4><ul><li>Ziopharm Oncology (<a href='https://seekingalpha.com/symbol/ZIOP' title='ZIOPHARM Oncology, Inc.'>ZIOP</a> <font color=\"green\">+8.7%</font>) is up on average volume following its <a href=\"https://seekingalpha.com/pr/17562713-ziopharm-oncology-names-nci-s-dr-drew-deniger-direct-tcr-t-cell-therapy-program\" target=\"_blank\">hiring </a>of NCI researcher Drew Deniger, Ph.D. to lead its program to genetically modify T cells to express neoantigen-specific T-cell receptors. He will join the company on July 29.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475736\" data-linked=\"Ziopharm up 9% on NCI researcher hire\" data-tweet=\"$ZIOP - Ziopharm up 9% on NCI researcher hire https://seekingalpha.com/news/3475736-ziopharm-up-9-on-nci-researcher-hire?source=tweet\" data-url=\"https://seekingalpha.com/news/3475736-ziopharm-up-9-on-nci-researcher-hire\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475733\" data-ts=\"1562169853\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LHX\" target=\"_blank\">LHX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475733-air-force-chooses-l3harris-for-prototype-replacement-radio\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Air Force chooses L3Harris for prototype replacement radio</a></h4><ul>   <li>The U.S. Air Force has <a href=\"https://seekingalpha.com/pr/17562886-us-air-force-selects-l3harris-technologies-develop-airborne-hf-replacement-radio-arcminus-190\" target=\"_blank\">chosen L3Harris Technologies</a> (<a href=\"http://seekingalpha.com/symbol/LHX\" target=\"_blank\">LHX</a> <font color=\"red\">-2.3%</font>) to prototype a replacement radio for the AN/ARC-190 airborne HF radio.</li>    <li>The contract covers the L3Harris Falcon Wideband Airborne HF Radio, a software-defined digital multimode radio that can augment space-based beyond-line-of-sight systems.</li>    <li>It will allow airmen to communicate data at speeds up to 10 times that on legacy ARC-190 radios, L3Harris says.</li>    <li>L3Harris will now be part of a competitive down select; initial development will lead to low-rate production followed by a full production decision.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475733\" data-linked=\"Air Force chooses L3Harris for prototype replacement radio\" data-tweet=\"$LHX - Air Force chooses L3Harris for prototype replacement radio https://seekingalpha.com/news/3475733-air-force-chooses-l3harris-for-prototype-replacement-radio?source=tweet\" data-url=\"https://seekingalpha.com/news/3475733-air-force-chooses-l3harris-for-prototype-replacement-radio\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475731\" data-ts=\"1562169732\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475731-omnova-solutions-and-quintana-energy-services-among-energy-materials-gainers-yuma-energy-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OMNOVA Solutions and Quintana Energy Services among Energy/Materials gainers; Yuma Energy and Covia among losers</a></h4><ul><li><b>Gainers: </b>OMNOVA Solutions (NYSE:<a href='https://seekingalpha.com/symbol/OMN' title='OMNOVA Solutions Inc.'>OMN</a>) <font color=\"green\">+55%</font>. Quintana Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/QES' title='Quintana Energy Services Inc.'>QES</a>) <font color=\"green\">+10%</font>. Blueknight Energy Partners (NASDAQ:<a href='https://seekingalpha.com/symbol/BKEP' title='Blueknight Energy Partners, L.P.'>BKEP</a>) <font color=\"green\">+7%</font>. Basic Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/BAS' title='Basic Energy Services, Inc.'>BAS</a>) <font color=\"green\">+7%</font>. Platinum Group Metals (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLG' title='Platinum Group Metals Ltd.'>PLG</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Covia (NYSE:<a href='https://seekingalpha.com/symbol/CVIA' title='Covia Holdings Corporation'>CVIA</a>) <font color=\"red\">-9%</font>. Schnitzer Steel Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/SCHN' title='Schnitzer Steel Industries, Inc.'>SCHN</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475731\" data-linked=\"OMNOVA Solutions and Quintana Energy Services among Energy/Materials gainers; Yuma Energy and Covia among losers\" data-tweet=\"$OMN $QES $BKEP - OMNOVA Solutions and Quintana Energy Services among Energy/Materials gainers; Yuma Energy and Covia among losers https://seekingalpha.com/news/3475731-omnova-solutions-and-quintana-energy-services-among-energy-materials-gainers-yuma-energy-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3475731-omnova-solutions-and-quintana-energy-services-among-energy-materials-gainers-yuma-energy-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475730\" data-ts=\"1562169639\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475730-natural-gas-inventory-build-slightly-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas inventory build slightly more than consensus</a></h4><ul><li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory:</a> <strong>+89 Bcf</strong> vs. +85 Bcf consensus, +98 Bcf last week.</li><li>Futures <font color=\"green\">+1.52%</font> to $2.274.</li><li>ETFs:<a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3475730\" data-linked=\"Natural gas inventory build slightly more than consensus\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas inventory build slightly more than consensus https://seekingalpha.com/news/3475730-natural-gas-inventory-build-slightly-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3475730-natural-gas-inventory-build-slightly-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>52&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475727\" data-ts=\"1562168609\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KPTI\" target=\"_blank\">KPTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475727-karyopharm-shares-halted-pending-news-shares-up-36\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Karyopharm shares halted pending news; shares up 36%</a></h4><ul><li>Nasdaq has suspended trading in Karyopharm Therapeutics (<a href='https://seekingalpha.com/symbol/KPTI' title='Karyopharm Therapeutics Inc.'>KPTI</a> <font color=\"green\">+36%</font>) pending the release of news, in this case pertaining to the FDA nod for multiple myeloma med XPOVIO (selinexor). The agency's formal action date is Saturday, July 6, meaning that an announcement should be made today considering the Independence Day weekend.</li><li><strong>Update</strong>: Shares are up <font color=\"green\">36%</font> on the resumption of trading. Volume is 12x normal.</li><li><strong>Update</strong>: The FDA announced <a href=\"https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-refractory-multiple-myeloma\" target=\"_blank\">accelerated approval</a>.</li><li><strong>Update</strong>: Management will host a conference call today at 1:30 pm ET to discuss the approval.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475727\" data-linked=\"Karyopharm shares halted pending news; shares up 36%\" data-tweet=\"$KPTI - Karyopharm shares halted pending news; shares up 36% https://seekingalpha.com/news/3475727-karyopharm-shares-halted-pending-news-shares-up-36?source=tweet\" data-url=\"https://seekingalpha.com/news/3475727-karyopharm-shares-halted-pending-news-shares-up-36\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475723\" data-ts=\"1562168040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475723-microcaps-among-financial-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps among financial movers</a></h4><ul><li><strong>Gainers:</strong> None.</li><li><b>Losers:</b> Puyi (NASDAQ:<a href='https://seekingalpha.com/symbol/PUYI' title='Puyi Inc.'>PUYI</a>) <font color=\"red\">-14%</font>. China Lending (NASDAQ:<a href='https://seekingalpha.com/symbol/CLDC' title='China Lending Corporation'>CLDC</a>) <font color=\"red\">-8%</font>. MDJM (NASDAQ:<a href='https://seekingalpha.com/symbol/MDJH' title='MDJM Ltd.'>MDJH</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475723\" data-linked=\"Microcaps among financial movers\" data-tweet=\"$PUYI $CLDC $MDJH - Microcaps among financial movers https://seekingalpha.com/news/3475723-microcaps-among-financial-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3475723-microcaps-among-financial-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475722\" data-ts=\"1562167922\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NIO\" target=\"_blank\">NIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475722-nio-rallies-after-tesla-deliveries-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nio rallies after Tesla deliveries beat</a></h4><ul> <li>Nio (NYSE:<a href='https://seekingalpha.com/symbol/NIO' title='NIO Inc.'>NIO</a>) is <font color=\"green\">up 13.44%</font> after Tesla reported Q2 deliveries ahead of expectations.</li> <li>It's not the first time that Nio has rocketed up or down off news related to Tesla.</li> <li>Today's rally is enough to push Nio to a six-week high.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475722\" data-linked=\"Nio rallies after Tesla deliveries beat\" data-tweet=\"$NIO - Nio rallies after Tesla deliveries beat https://seekingalpha.com/news/3475722-nio-rallies-after-tesla-deliveries-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3475722-nio-rallies-after-tesla-deliveries-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>48&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475721\" data-ts=\"1562167914\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475721-aqua-metals-among-industrial-gainers-pioneer-power-solutions-and-china-advanced-construction\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aqua Metals among industrial gainers; Pioneer Power Solutions and China Advanced Construction Materials in losers</a></h4><ul><li><b>Gainers: </b>ReTo Eco-Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/RETO' title='ReTo Eco-Solutions, Inc.'>RETO</a>) <font color=\"green\">+9%</font>. Aqua Metals (NASDAQ:<a href='https://seekingalpha.com/symbol/AQMS' title='Aqua Metals, Inc.'>AQMS</a>) <font color=\"green\">+6%</font>. Mayville Engineering Company (NYSE:<a href='https://seekingalpha.com/symbol/MEC' title='Mayville Engineering Company, Inc.'>MEC</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Pioneer Power Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/PPSI' title='Pioneer Power Solutions, Inc.'>PPSI</a>) <font color=\"red\">-6%</font>. China Advanced Construction Materials (NASDAQ:<a href='https://seekingalpha.com/symbol/CADC' title='China Advanced Construction Materials Group, Inc.'>CADC</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475721\" data-linked=\"Aqua Metals among industrial gainers; Pioneer Power Solutions and China Advanced Construction Materials in losers\" data-tweet=\"$RETO $AQMS $MEC - Aqua Metals among industrial gainers; Pioneer Power Solutions and China Advanced Construction Materials in losers https://seekingalpha.com/news/3475721-aqua-metals-among-industrial-gainers-pioneer-power-solutions-and-china-advanced-construction?source=tweet\" data-url=\"https://seekingalpha.com/news/3475721-aqua-metals-among-industrial-gainers-pioneer-power-solutions-and-china-advanced-construction\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475719\" data-ts=\"1562167486\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475719-nio-symc-and-usna-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NIO, SYMC and USNA among midday movers</a></h4><ul><li><strong>Gainers: </strong>OMNOVA Solutions (NYSE:<a href='https://seekingalpha.com/symbol/OMN' title='OMNOVA Solutions Inc.'>OMN</a>) <font color=\"green\">+55%</font>. SELLAS Life Sciences Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SLS' title='SELLAS Life Sciences Group, Inc.'>SLS</a>) <font color=\"green\">+46%</font>. Karyopharm Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/KPTI' title='Karyopharm Therapeutics Inc.'>KPTI</a>) <font color=\"green\">+36%</font>. One Stop Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/OSS' title='One Stop Systems, Inc.'>OSS</a>) <font color=\"green\">+26%</font>. NIO (NYSE:<a href='https://seekingalpha.com/symbol/NIO' title='NIO Inc.'>NIO</a>) <font color=\"green\">+15%</font>. Corvus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CRVS' title='Corvus Pharmaceuticals, Inc.'>CRVS</a>) <font color=\"green\">+15%</font>. Melinta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MLNT' title='Melinta Therapeutics, Inc.'>MLNT</a>) <font color=\"green\">+17%</font>. Symantec Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/SYMC' title='Symantec Corporation'>SYMC</a>) <font color=\"green\">+14%</font>. Spring Bank Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SBPH' title='Spring Bank Pharmaceuticals, Inc.'>SBPH</a>) <font color=\"green\">+14%</font>. AquaBounty Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/AQB' title='AquaBounty Technologies, Inc.'>AQB</a>) <font color=\"green\">+12%</font>.</li> <li><strong>Losers: </strong>GlobalSCAPE (NYSEMKT:<a href='https://seekingalpha.com/symbol/GSB' title='GlobalSCAPE, Inc.'>GSB</a>) <font color=\"red\">-17%</font>. USANA Health Sciences (NYSE:<a href='https://seekingalpha.com/symbol/USNA' title='USANA Health Sciences, Inc.'>USNA</a>) <font color=\"red\">-16%</font>. Advaxis (NASDAQ:<a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis, Inc.'>ADXS</a>) <font color=\"red\">-15%</font>. Puyi (NASDAQ:<a href='https://seekingalpha.com/symbol/PUYI' title='Puyi Inc.'>PUYI</a>) <font color=\"red\">-14%</font>. Akerna (NASDAQ:<a href='https://seekingalpha.com/symbol/KERN' title='Akerna Corp.'>KERN</a>) <font color=\"red\">-12%</font>. Oasmia Pharmaceutical AB (publ) (NASDAQ:<a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical AB &#40;publ&#41;'>OASM</a>) <font color=\"red\">-12%</font>. GTY Technology Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/GTYH' title='GTY Technology Holdings Inc.'>GTYH</a>) <font color=\"red\">-10%</font>. Covia Holdings Corporation (NYSE:<a href='https://seekingalpha.com/symbol/CVIA' title='Covia Holdings Corporation'>CVIA</a>) <font color=\"red\">-10%</font>. Pier 1 Imports (NYSE:<a href='https://seekingalpha.com/symbol/PIR' title='Pier 1 Imports, Inc.'>PIR</a>) <font color=\"red\">-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475719\" data-linked=\"NIO, SYMC and USNA among midday movers\" data-tweet=\"$OMN $SLS $KPTI - NIO, SYMC and USNA among midday movers https://seekingalpha.com/news/3475719-nio-symc-and-usna-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3475719-nio-symc-and-usna-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475714\" data-ts=\"1562166062\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475714-tesla-and-kellogg-among-consumer-gainers-nu-skin-enterprises-only-loser\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla and Kellogg among consumer gainers; Nu Skin Enterprises only loser</a></h4><ul><li><b>Gainers: </b>NIO (NYSE:<a href='https://seekingalpha.com/symbol/NIO' title='NIO Inc.'>NIO</a>) <font color=\"green\">+16%</font>. Xcel Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/XELB' title='Xcel Brands, Inc.'>XELB</a>) <font color=\"green\">+14%</font>. Kellogg Company (NYSE:<a href='https://seekingalpha.com/symbol/K' title='Kellogg Company'>K</a>) <font color=\"green\">+6%</font>. Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Nu Skin Enterprises (NYSE:<a href='https://seekingalpha.com/symbol/NUS' title='Nu Skin Enterprises, Inc.'>NUS</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475714\" data-linked=\"Tesla and Kellogg among consumer gainers; Nu Skin Enterprises only loser\" data-tweet=\"$NIO $XELB $K - Tesla and Kellogg among consumer gainers; Nu Skin Enterprises only loser https://seekingalpha.com/news/3475714-tesla-and-kellogg-among-consumer-gainers-nu-skin-enterprises-only-loser?source=tweet\" data-url=\"https://seekingalpha.com/news/3475714-tesla-and-kellogg-among-consumer-gainers-nu-skin-enterprises-only-loser\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475711\" data-ts=\"1562165605\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/K\" target=\"_blank\">K</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475711-kelloggplus-6-off-plant-based-meat-buzz\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kellogg +6% off plant-based meat buzz</a></h4><ul> <li>Kellogg (NYSE:<a href='https://seekingalpha.com/symbol/K' title='Kellogg Company'>K</a>) is <font color=\"green\">up 5.75%</font> after Barron's mentions the potential gold mine the food company is sitting on with its veggie-focused Morningstar Farms asset.</li> <li>Seeking Alpha <a href=\"https://seekingalpha.com/news/3475334-kellogg-seen-vegetarian-sleeper\" target=\"_blank\">tipped off</a> yesterday before today's notable rally that a potential IPO by Kellogg's of Morningstar Farms was being speculated on outside of the company.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3475711\" data-linked=\"Kellogg +6% off plant-based meat buzz\" data-tweet=\"$K - Kellogg +6% off plant-based meat buzz https://seekingalpha.com/news/3475711-kelloggplus-6-off-plant-based-meat-buzz?source=tweet\" data-url=\"https://seekingalpha.com/news/3475711-kelloggplus-6-off-plant-based-meat-buzz\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475710\" data-ts=\"1562165471\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KPTI\" target=\"_blank\">KPTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475710-fda-oks-karyopharms-selinexor-for-treatment-resistant-multiple-myeloma-shares-up-36\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Karyopharm&#39;s selinexor for treatment-resistant multiple myeloma; shares up 36%</a></h4><ul><li>Karyopharm Therapeutics (<a href='https://seekingalpha.com/symbol/KPTI' title='Karyopharm Therapeutics Inc.'>KPTI</a> <font color=\"green\">+35.5%</font>) is up on more than a 6x surge in volume in response to the FDA nod for XPOVIO (selinexor) for the treatment of penta-refractory multiple myeloma.</li><li>The agency's action date was July 6.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475710\" data-linked=\"FDA OKs Karyopharm&#39;s selinexor for treatment-resistant multiple myeloma; shares up 36%\" data-tweet=\"$KPTI - FDA OKs Karyopharm&#39;s selinexor for treatment-resistant multiple myeloma; shares up 36% https://seekingalpha.com/news/3475710-fda-oks-karyopharms-selinexor-for-treatment-resistant-multiple-myeloma-shares-up-36?source=tweet\" data-url=\"https://seekingalpha.com/news/3475710-fda-oks-karyopharms-selinexor-for-treatment-resistant-multiple-myeloma-shares-up-36\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475708\" data-ts=\"1562164954\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCK\" target=\"_blank\">MCK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475708-drug-distributors-rally-after-fresh-round-of-price-hikes-from-makers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Drug distributors rally after fresh round of price hikes from makers</a></h4><ul><li>Pharmaceutical wholesalers McKesson (<a href='https://seekingalpha.com/symbol/MCK' title='McKesson Corporation'>MCK</a> <font color=\"green\">+4.2%</font>), Cardinal Health (<a href='https://seekingalpha.com/symbol/CAH' title='Cardinal Health, Inc.'>CAH</a> <font color=\"green\">+3.2%</font>) and AmerisourceBergen (<a href='https://seekingalpha.com/symbol/ABC' title='AmerisourceBergen Corporation'>ABC</a> <font color=\"green\">+3.5%</font>) rally after a number of drug makers <a href=\"https://seekingalpha.com/news/3475290-u-s-drugmakers-institute-new-round-increases\" target=\"_blank\">hiked prices</a> earlier this week, apparently emboldening investors that efforts to corral increases will fizzle.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475708\" data-linked=\"Drug distributors rally after fresh round of price hikes from makers\" data-tweet=\"$MCK $CAH $ABC - Drug distributors rally after fresh round of price hikes from makers https://seekingalpha.com/news/3475708-drug-distributors-rally-after-fresh-round-of-price-hikes-from-makers?source=tweet\" data-url=\"https://seekingalpha.com/news/3475708-drug-distributors-rally-after-fresh-round-of-price-hikes-from-makers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475705\" data-ts=\"1562164796\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUS\" target=\"_blank\">NUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475705-nu-skinminus-6-after-usana-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nu Skin -6% after USANA warning</a></h4><ul> <li>Nu Skin (<a href='https://seekingalpha.com/symbol/NUS' title='Nu Skin Enterprises, Inc.'>NUS</a> <font color='red'>-5.7%</font>) falls sharply after traders latch on to the <a href=\"https://seekingalpha.com/news/3475531-usana-cuts-guidance-due-china-headwinds\" target=\"_blank\">weak guidance</a> posted by USANA Health Sciences yesterday after the market closed.</li> <li>Jefferies warns that the comments from USANA management on China don't bode well for Nu Skin.</li> <li>Shares of Nu Skin are only about a dollar away from the 52-week low of $44.36.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475705\" data-linked=\"Nu Skin -6% after USANA warning\" data-tweet=\"$NUS - Nu Skin -6% after USANA warning https://seekingalpha.com/news/3475705-nu-skinminus-6-after-usana-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3475705-nu-skinminus-6-after-usana-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475702\" data-ts=\"1562164401\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475702-concord-medical-services-leads-healthcare-gainers-advaxis-and-usana-health-sciences-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Concord Medical Services leads healthcare gainers; Advaxis and USANA Health Sciences among losers</a></h4><ul><li><b>Gainers: </b>Concord Medical Services (NYSE:<a href='https://seekingalpha.com/symbol/CCM' title='Concord Medical Services Holdings Limited'>CCM</a>) <font color=\"green\">+11%</font>. Cerecor (NASDAQ:<a href='https://seekingalpha.com/symbol/CERC' title='Cerecor Inc.'>CERC</a>) <font color=\"green\">+9%</font>. Corvus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CRVS' title='Corvus Pharmaceuticals, Inc.'>CRVS</a>) <font color=\"green\">+8%</font>. China SXT Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SXTC' title='China SXT Pharmaceuticals, Inc.'>SXTC</a>) <font color=\"green\">+7%</font>. Dova Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DOVA' title='Dova Pharmaceuticals, Inc.'>DOVA</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>USANA Health Sciences (NYSE:<a href='https://seekingalpha.com/symbol/USNA' title='USANA Health Sciences, Inc.'>USNA</a>) <font color=\"red\">-17%</font>. Advaxis (NASDAQ:<a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis, Inc.'>ADXS</a>) <font color=\"red\">-12%</font>. Oasmia Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical AB &#40;publ&#41;'>OASM</a>) <font color=\"red\">-12%</font>. Fulgent Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/FLGT' title='Fulgent Genetics, Inc.'>FLGT</a>) <font color=\"red\">-11%</font>. Ovid Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OVID' title='Ovid Therapeutics Inc.'>OVID</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475702\" data-linked=\"Concord Medical Services leads healthcare gainers; Advaxis and USANA Health Sciences among losers\" data-tweet=\"$CCM $CERC $CRVS - Concord Medical Services leads healthcare gainers; Advaxis and USANA Health Sciences among losers https://seekingalpha.com/news/3475702-concord-medical-services-leads-healthcare-gainers-advaxis-and-usana-health-sciences-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3475702-concord-medical-services-leads-healthcare-gainers-advaxis-and-usana-health-sciences-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475700\" data-ts=\"1562164270\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475700-crude-inventory-declines-slightly\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crude inventory declines slightly</a></h4><ul><li><a href=\"http://ir.eia.gov/wpsr/wpsrsummary.pdf\" target=\"_blank\">EIA Petroleum Inventories:</a> Crude <strong>-1.1M</strong> barrels vs. -3.0M consensus, -12.8M last week.</li><li>Gasoline <strong>-1.6M</strong> barrels vs. -2.2M consensus, -1.0M last week.</li><li>Distillates <strong>+1.4</strong><strong>M</strong> barrels vs. -1.0M consensus, -2.4M last week.</li><li>Futures <font color=\"green\">+1.1%</font> to $56.88.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475700\" data-linked=\"Crude inventory declines slightly\" data-tweet=\"$USO $OIL $UCO - Crude inventory declines slightly https://seekingalpha.com/news/3475700-crude-inventory-declines-slightly?source=tweet\" data-url=\"https://seekingalpha.com/news/3475700-crude-inventory-declines-slightly\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>101&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475698\" data-ts=\"1562164021\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SXTC\" target=\"_blank\">SXTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475698-china-sxt-pharma-up-8-on-production-of-health-food-supplements\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China SXT Pharma up 8% on production of health food supplements</a></h4><ul><li>Thinly traded micro cap China SXT Pharmaceuticals (<a href='https://seekingalpha.com/symbol/SXTC' title='China SXT Pharmaceuticals, Inc.'>SXTC</a> <font color=\"green\">+7.8%</font>) is up on more than a 4x surge in volume, albeit on turnover of only 513K shares, in apparent response to its <a href=\"https://seekingalpha.com/pr/17562609-china-sxt-pharmaceuticals-inc-announces-tcm-homologous-supplements-production\" target=\"_blank\">announcement </a>that it has begun producing TCM Homologous Supplements, a type of health food, in China.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475698\" data-linked=\"China SXT Pharma up 8% on production of health food supplements\" data-tweet=\"$SXTC - China SXT Pharma up 8% on production of health food supplements https://seekingalpha.com/news/3475698-china-sxt-pharma-up-8-on-production-of-health-food-supplements?source=tweet\" data-url=\"https://seekingalpha.com/news/3475698-china-sxt-pharma-up-8-on-production-of-health-food-supplements\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475686\" data-ts=\"1562162330\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475686-stolt-nielsenminus-4_1-on-weak-margins\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stolt-Nielsen -4.1% on weak margins</a></h4><ul><li>Stolt-Nielsen (<a href='https://seekingalpha.com/symbol/SOIEF' title='Stolt-Nielsen Limited'>OTCPK:SOIEF</a>) reported <a href=\"https://ml-eu.globenewswire.com/Resource/Download/02e57680-c83c-4104-9d9a-6c57dddb9e7d\" target=\"_blank\">Q2</a> revenue decreased of 4.1% Y/Y to $518.9M.</li><li>Segment revenue: Tankers $293.6M (-4.9% Y/Y), Terminals $63.1M (-1.3% Y/Y), Tank containers $135.8M (-5.2% Y/Y) and Stolt Sea farm $25.4M (+4.1% Y/Y).</li><li>Q2 Overall margins: Gross <font color=\"red\">declined 104 bps</font> to 17.1% and operating <font color=\"red\">declined 79 bps</font> to 8.17%.</li><li>Segment operating margin: Tankers <font color=\"red\">declined 423 bps</font> to 4.36%; Terminals <font color=\"red\">declined 39 bps</font> to 31.2%; Tank containers <font color=\"red\">declined 385 bps</font> to 9.28% and Stolt Sea Farm <font color=\"red\">declined 1,300 bps</font> to 2.95%.</li><li>Stolt tankers joint service sailed-in time-charter index for H1 was 0.53, compared with 0.58 for the same period.</li><li>At Stolthaven terminals tank capacity utilisation rate increased to 91.6% in H1 2019 from 89.3% in H1 2018.</li><li>Stolt Tank Containers experienced a reduced number of shipments during H1 2019, compared Y/Y due to increased competition and price pressure.</li><li>Leased units increased by 2,474 tanks, net of off-hires, in H1 2019 and at the same time, Stolt Tank Containers retired 278 older tank containers.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3475593-stolt-nielsen-eps-misses-0_12-beats-revenue\" target=\"_blank\">Stolt-Nielsen EPS misses by $0.12, beats on revenue</a> (Jul. 03 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3475686\" data-linked=\"Stolt-Nielsen -4.1% on weak margins\" data-tweet=\"$SOIEF - Stolt-Nielsen -4.1% on weak margins https://seekingalpha.com/news/3475686-stolt-nielsenminus-4_1-on-weak-margins?source=tweet\" data-url=\"https://seekingalpha.com/news/3475686-stolt-nielsenminus-4_1-on-weak-margins\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475684\" data-ts=\"1562162162\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAND\" target=\"_blank\">BAND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475684-bandwidthplus-4_8-jpmorgan-starts-overweight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bandwidth +4.8% as JPMorgan starts at Overweight</a></h4><ul>   <li>Bandwidth (NASDAQ:<a href='https://seekingalpha.com/symbol/BAND' title='Bandwidth Inc.'>BAND</a>) is <font color=\"green\">up 4.8%</font> after an initiation at Overweight by JPMorgan.</li>    <li>The firm cites Bandwidth's customer list and growth in the CPaaS market as positives, and calls out that the company owning its own VOIP network offers cost and quality control.</li>    <li>It's set a price target of $90, implying 14% upside from here.</li>    <li>Sell-side analysts <a href=\"https://seekingalpha.com/symbol/BAND/ratings/sell-side-ratings\" target=\"_blank\">rate it an Outperform on average</a>, and <a href=\"https://seekingalpha.com/symbol/BAND/ratings/author-ratings\" target=\"_blank\">Seeking Alpha authors are Bullish</a> overall as well. The stock has a <a href=\"https://seekingalpha.com/symbol/BAND/ratings/quant-ratings\" target=\"_blank\">Quant Rating of Neutral</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3475684\" data-linked=\"Bandwidth +4.8% as JPMorgan starts at Overweight\" data-tweet=\"$BAND - Bandwidth +4.8% as JPMorgan starts at Overweight https://seekingalpha.com/news/3475684-bandwidthplus-4_8-jpmorgan-starts-overweight?source=tweet\" data-url=\"https://seekingalpha.com/news/3475684-bandwidthplus-4_8-jpmorgan-starts-overweight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475668\" data-ts=\"1562159599\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475668-tsla-xspa-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TSLA, XSPA among premarket gainers</a></h4><ul><li>OMNOVA Solutions (NYSE:<a href='https://seekingalpha.com/symbol/OMN' title='OMNOVA Solutions Inc.'>OMN</a>) <font color=\"green\">+55%</font> on <a href=\"https://seekingalpha.com/news/3475611-omnova-plus-50-percent-acquisition-synthomer\" target=\"_blank\">acquisition</a> by Synthomer.</li><li>One Stop Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/OSS' title='One Stop Systems, Inc.'>OSS</a>) <font color=\"green\">+20%</font> on five-year OEM and supply <a href=\"https://seekingalpha.com/pr/17562717-oss-signs-five-year-60-million-oem-agreement-disguise-systems-media-entertainment-servers\" target=\"_blank\">agreement</a> with Disguise Systems for media and entertainment servers.</li><li>Symantec (NASDAQ:<a href='https://seekingalpha.com/symbol/SYMC' title='Symantec Corporation'>SYMC</a>) <font color=\"green\">+15%</font> on <a href=\"https://seekingalpha.com/news/3475635-analysts-positive-broadcom-symantec-deal\" target=\"_blank\">analyst upgrade</a>.</li><li>XpresSpa Group (NASDAQ:<a href='https://seekingalpha.com/symbol/XSPA' title='XpresSpa Group, Inc.'>XSPA</a>) <font color=\"green\">+11%</font> after <a href=\"https://seekingalpha.com/pr/17562417-xpresspa-issues-public-statement-response-second-lawsuit-made-disgruntled-founders-company\" target=\"_blank\">responding</a> to a lawsuit brought by Moreton Binn and Marisol Binn.</li><li>Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) <font color=\"green\">+7%</font> after <a href=\"https://seekingalpha.com/news/3475527-tesla-plus-7-percent-topping-q2-deliveries-expectations\" target=\"_blank\">topping Q2</a> deliveries expectations.</li><li>OrganiGram Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/OGI' title='OrganiGram Holdings Inc.'>OGI</a>) <font color=\"green\">+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475668\" data-linked=\"TSLA, XSPA among premarket gainers\" data-tweet=\"$OMN $OSS $NLOK - TSLA, XSPA among premarket gainers https://seekingalpha.com/news/3475668-tsla-xspa-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3475668-tsla-xspa-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475666\" data-ts=\"1562159271\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475666-usna-adxs-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">USNA, ADXS among premarket losers</a></h4><ul><li>USANA Health Sciences (NYSE:<a href='https://seekingalpha.com/symbol/USNA' title='USANA Health Sciences, Inc.'>USNA</a>) <font color=\"red\">-19%</font> on <a href=\"https://seekingalpha.com/news/3475652-usana-18-percent-premarket-guidance-cut\" target=\"_blank\">guidance cut</a>.</li><li>Advaxis (NASDAQ:<a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis, Inc.'>ADXS</a>) <font color=\"red\">-11%</font> as it files for <a href=\"https://seekingalpha.com/news/3475567-advaxis-minus-6_9-percent-files-capital-raise\" target=\"_blank\">capital raise</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475666\" data-linked=\"USNA, ADXS among premarket losers\" data-tweet=\"$USNA $ADXS - USNA, ADXS among premarket losers https://seekingalpha.com/news/3475666-usna-adxs-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3475666-usna-adxs-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475661\" data-ts=\"1562158495\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475661-unilever-eyes-divestments-down-under\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Unilever eyes divestments Down Under</a></h4><ul> <li>Unilever (<a href='https://seekingalpha.com/symbol/UN' title='Unilever N.V.'>UN</a>, <a href='https://seekingalpha.com/symbol/UL' title='Unilever PLC'>UL</a>) has invited bankers in for an <a href=\"https://www.afr.com/street-talk/unilever-s-bankers-invite-pe-for-tea-as-part-of-wider-review-20190703-p523mt\" target=\"_blank\">informal strategic review</a> of its business in Australia and New Zealand, according to Australian Financial Review.</li> <li>\"The private equity types were told there were no brands for sale, however the meetings clearly flagged that divestments were an option. T2 was one of the names mentioned,\" reports AFR.</li><li>Shares of Unilever are <font color=\"green\">up 1.8%</font> in Amsterdam trading.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3475661\" data-linked=\"Unilever eyes divestments Down Under\" data-tweet=\"$UN $UL - Unilever eyes divestments Down Under https://seekingalpha.com/news/3475661-unilever-eyes-divestments-down-under?source=tweet\" data-url=\"https://seekingalpha.com/news/3475661-unilever-eyes-divestments-down-under\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475659\" data-ts=\"1562158375\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTST\" target=\"_blank\">CTST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475659-canntrust-provides-cultivation-and-shipment-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CannTrust provides cultivation and shipment update</a></h4><ul> <li>CannTrust Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CTST' title='CannTrust Holdings Inc.'>CTST</a>) <a href=\"https://seekingalpha.com/pr/17562579-canntrust-provides-update-outdoor-cultivation-first-shipment-australia\" target=\"_blank\">announces</a> an update on its outdoor cultivation operation in British Columbia and its first shipment of capsule and dry flower products to Australia.</li>                   <li>The Company closed purchase of its first 81 acres of land in British Columbia and estimated 75,000kg of cannabis production in 2019.</li><li>As CannTrust is yet to receive Health Canada permit, its production capacity range from this operation is now estimated from 0 to 15,000kg in 2019, subject to the timing and receipt of regulatory approvals.</li><li>If a crop is not planted by August 5, 2019, there will be no outdoor harvest in 2019.</li> <li>CannTrust expects to reach a definitive agreement for a long-term lease for an additional 160 acres in the near term and that all properties. Between these two properties, it expects to produce between 100,000kg to 200,000kg of cannabis in British Columbia in 2020, subject to regulatory approvals.</li>   <li>Also, the Company completed its first shipment of CBD, THC and 1:1 CBD:THC vegan capsules and dry flower products to Australia. These products will be resold by its partner Cannatrek Ltd. to medical patients in Australia.</li><li>shares are up <font color=\"green\">3%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475659\" data-linked=\"CannTrust provides cultivation and shipment update\" data-tweet=\"$CTST - CannTrust provides cultivation and shipment update https://seekingalpha.com/news/3475659-canntrust-provides-cultivation-and-shipment-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3475659-canntrust-provides-cultivation-and-shipment-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475655\" data-ts=\"1562157994\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGC\" target=\"_blank\">CGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475655-canopys-linton-i-was-terminated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canopy&#39;s Linton: &quot;I was terminated&quot;</a></h4><ul><li><a href=\"https://www.cnbc.com/2019/07/03/canopy-growth-co-ceo-to-step-down.html\" target=\"_blank\">Calling into CNBC</a>, now former co-CEO of Canopy Growth (NYSE:<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a>) Bruce Linton, says \"stepping down\" (the language in the <a href=\"https://seekingalpha.com/pr/17562529-b-canopy-b-growth-announces-leadership-transition\" target=\"_blank\">press release</a>) isn't the correct phrase.</li><li>As to who might have done the firing, Constellation Brands (NYSE:<a href='https://seekingalpha.com/symbol/STZ' title='Constellation Brands, Inc.'>STZ</a>) is <a href=\"https://seekingalpha.com/news/3475643-constellation-brands-eyed-shock-canopy-growth-development\" target=\"_blank\">under some pressure</a>, and an owner of what could soon be a majority stake in Canopy.</li><li>\"It's just not a great day for Bruce,\" says Linton, reminding he's an owner of 18M shares of Canopy.</li><li>Shares have bounced from their worst levels, now <font color=\"red\">down 3.8% </font>premarket. STZ is <font color=\"red\">down 0.8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475655\" data-linked=\"Canopy&#39;s Linton: &quot;I was terminated&quot;\" data-tweet=\"$CGC $CGC $STZ - Canopy&#39;s Linton: &quot;I was terminated&quot; https://seekingalpha.com/news/3475655-canopys-linton-i-was-terminated?source=tweet\" data-url=\"https://seekingalpha.com/news/3475655-canopys-linton-i-was-terminated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>170&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475652\" data-ts=\"1562157671\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USNA\" target=\"_blank\">USNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475652-usana-down-18-premarket-on-guidance-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">USANA down 18% premarket on guidance cut</a></h4><ul><li>USANA Health Sciences (NYSE:<a href='https://seekingalpha.com/symbol/USNA' title='USANA Health Sciences, Inc.'>USNA</a>) slumps <font color=\"red\">18%</font> premarket on light volume on the heels of a <a href=\"https://seekingalpha.com/news/3475531-usana-health-sciences-provides-2019-outlook-cut\" target=\"_blank\">downward revision</a> to guidance citing a \"challenging\" environment in China.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475652\" data-linked=\"USANA down 18% premarket on guidance cut\" data-tweet=\"$USNA - USANA down 18% premarket on guidance cut https://seekingalpha.com/news/3475652-usana-down-18-premarket-on-guidance-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3475652-usana-down-18-premarket-on-guidance-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475651\" data-ts=\"1562157603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475651-tesla-takes-victory-lap\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla takes a victory lap</a></h4><ul> <li>Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) is holding on to its AH gain from yesterday following the company's above-consensus report of 95.2K deliveries in Q2.</li> <li>Model 3 deliveries of 77,550 during the quarter came in comfortably ahead of the final Street consensus estimate of 74,100 to the surprise of some sensing desperation out of Fremont.</li> <li>\"Taking a step back, with Musk and Tesla's back against the wall and many doomsday predictors abound the company came through swinging with a strong 2Q delivery unit number that will help restore credibility to the story in the near-term as Musk talked the talked, but finally walked the walk this quarter,\" writes Wedbush's Dan Ives on the deliveries print.</li>  <li>While Tesla is hearing other positive comments from Wall Street analysts for the Q2 deliveries push, there aren't any upgrades or price target hikes arriving in this morning. That could be because Tesla didn't update its full-year forecast for 360K to 400K deliveries or back up Elon Musk's tease of a profitable second half of the year. There is also the impact of the lower federal EV tax credit post-July 1 to factor in.</li><li>Tesla is likely to spill Q2 earnings sometime during the first week of August, giving investors a few weeks to position themselves for the crucial second-half guidance update that should arrive with the report.</li> <li>Shares of Tesla are <font color=\"green\">up 7.01%</font> premarket to $240.26.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475651\" data-linked=\"Tesla takes a victory lap\" data-tweet=\"$TSLA - Tesla takes a victory lap https://seekingalpha.com/news/3475651-tesla-takes-victory-lap?source=tweet\" data-url=\"https://seekingalpha.com/news/3475651-tesla-takes-victory-lap\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>912&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475647\" data-ts=\"1562156971\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDHL\" target=\"_blank\">RDHL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475647-redhill-bios-talicia-nabs-accelerated-review-status-for-h-pylori-infection\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RedHill Bio&#39;s Talicia nabs accelerated review status for H. pylori infection</a></h4><ul> <li>The FDA has <a href=\"https://seekingalpha.com/pr/17562566-redhill-biopharma-announces-fda-acceptance-new-drug-application-talicia\" target=\"_blank\">accepted</a> for review RedHill Biopharma's (NASDAQ:<a href='https://seekingalpha.com/symbol/RDHL' title='RedHill Biopharma Ltd.'>RDHL</a>) NDA for Talicia (RHB-105) for<em> H. pylori</em> infection. The NDA has also been granted Priority Review designation.</li><li>PDUFA action date is November 2, 2019.</li>     <li>If approved, Talicia would be eligible for eight years of U.S. market exclusivity.</li>    <li>Talicia (RHB-105) is an oral capsule combination of two antibiotics, rifabutin, and amoxicillin, and a proton pump inhibitor, omeprazole.</li><li>Shares are up <font color=\"green\">3%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3475647\" data-linked=\"RedHill Bio&#39;s Talicia nabs accelerated review status for H. pylori infection\" data-tweet=\"$RDHL - RedHill Bio&#39;s Talicia nabs accelerated review status for H. pylori infection https://seekingalpha.com/news/3475647-redhill-bios-talicia-nabs-accelerated-review-status-for-h-pylori-infection?source=tweet\" data-url=\"https://seekingalpha.com/news/3475647-redhill-bios-talicia-nabs-accelerated-review-status-for-h-pylori-infection\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475643\" data-ts=\"1562156225\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STZ\" target=\"_blank\">STZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475643-constellation-brands-eyed-after-shock-canopy-growth-development\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Constellation Brands eyed after shock Canopy Growth development</a></h4><ul> <li>Constellation Brands (NYSE:<a href='https://seekingalpha.com/symbol/STZ' title='Constellation Brands, Inc.'>STZ</a>) is on watch after the <a href=\"https://seekingalpha.com/news/3475632-canopy-growth-8-percent-co-ceo-exits\" target=\"_blank\">shock exit</a> of Canopy Growth co-CEO Bruce Linton this morning.</li> <li>The ink wasn't even dry on the press release on the stepping down of the high-profile cannabis advocate before some <a href=\"https://www.bnnbloomberg.ca/i-agreed-my-turn-is-over-canopy-growth-s-bruce-linton-stepping-down-1.1281999\" target=\"_blank\">conjecture</a> was made that Constellation's fingerprints are all over Linton's exit.</li> <li>Last week, Constellation Brands CEO William Newlands sounded grumpy about Canopy Growth during the firm's earnings call (<a href=\"https://seekingalpha.com/article/4272719-constellation-brands-inc-stz-ceo-william-newlands-q1-2020-results-earnings-call-transcript\" target=\"_blank\">transcript</a>). \"While we remain happy with our investment in the cannabis space and its long-term potential, we were not pleased with Canopy\u2019s recent reported year-end results,\" he stated.</li> <li>Constellation holds a stake in Canopy Growth that could rise to over 50% if warrants are executed.</li> <li>STZ <font color=\"red\">-1.84%</font> premarket to $195.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475643\" data-linked=\"Constellation Brands eyed after shock Canopy Growth development\" data-tweet=\"$STZ - Constellation Brands eyed after shock Canopy Growth development https://seekingalpha.com/news/3475643-constellation-brands-eyed-after-shock-canopy-growth-development?source=tweet\" data-url=\"https://seekingalpha.com/news/3475643-constellation-brands-eyed-after-shock-canopy-growth-development\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475638\" data-ts=\"1562155716\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISCA\" target=\"_blank\">ISCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475638-international-speedway-missed-q2-estimates-and-reaffirms-fy2019-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">International Speedway missed Q2 estimates and reaffirms FY2019 guidance</a></h4><ul><li>International Speedway (NASDAQ:<a href='https://seekingalpha.com/symbol/ISCA' title='International Speedway Corporation'>ISCA</a>) reports admission revenue fell 5% to $24.39M in <a href=\"https://seekingalpha.com/pr/17562596-international-speedway-corporation-reports-financial-results-second-quarter-fiscal-2019\" target=\"_blank\">Q2</a>.</li><li>Motorsports and other event related revenue down 4.9% to $126.78M.</li><li>Food, beverage, and merchandise revenue expanded 64.6% to $11.36M.</li><li>Operating margin rate slipped 90 bps to 9.2%.</li><li>Adjusted EBITDA rose 2.5% to $52.06M.</li><li><b>FY2019 Guidance</b>: Revenue: $685M to $705M; Adjusted EBITDA: $230M to $250M; Operating margin: 13.5% to 16%; Tax rate: 25% to 26%; Diluted EPS: $1.85 to $2.15.</li><li>ISCA <font color=\"green\">+1.31%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3475623-international-speedway-eps-misses-0_03-misses-revenue\" target=\"_blank\">International Speedway EPS misses by $0.03, misses on revenue</a> (July 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3475638\" data-linked=\"International Speedway missed Q2 estimates and reaffirms FY2019 guidance\" data-tweet=\"$ISCA - International Speedway missed Q2 estimates and reaffirms FY2019 guidance https://seekingalpha.com/news/3475638-international-speedway-missed-q2-estimates-and-reaffirms-fy2019-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3475638-international-speedway-missed-q2-estimates-and-reaffirms-fy2019-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475635\" data-ts=\"1562155143\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475635-analysts-positive-on-broadcom-symantec-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts positive on Broadcom-Symantec deal</a></h4><ul> <li>Wedbush analyst Dan Ives weighs in on <a href=\"https://seekingalpha.com/news/3475584-broadcom-advanced-talks-buy-symantec-bloomberg\" target=\"_blank\">reports</a> that Broadcom (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Inc.'>AVGO</a>) is in \"advanced talks\" to acquire Symantec (NASDAQ:<a href='https://seekingalpha.com/symbol/SYMC' title='Symantec Corporation'>SYMC</a>).</li> <li>\"If Broadcom goes down this route we believe there are some significant synergies and cost cutting on the enterprise side, coupled with a cash cow machine on the consumer front, and in terms of a ~$18 billion to $20 billion deal this would make sense on paper although many questions would still remain about the overall software strategy going forward,\" Ives.</li> <li>\"We continue to believe strategic/financial buyers are abound in the software landscape looking for M&amp;A as the secular trends around cyber security and cloud will potentially lead to an aggressive period of consolidation over the next 12 to 18 months with Broadcom/Symantec potentially kicking off the fireworks over the next few days,\" he adds.</li><li>Piper Jaffray and Bernstein are also out with positive notes on the potential combination of the two tech companies.</li>  <li>AVGO is <font color=\"red\">down 4.20%</font> premarket to $283.00. SYMC <font color=\"green\">+17.59%</font> to $26.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475635\" data-linked=\"Analysts positive on Broadcom-Symantec deal\" data-tweet=\"$AVGO $NLOK - Analysts positive on Broadcom-Symantec deal https://seekingalpha.com/news/3475635-analysts-positive-on-broadcom-symantec-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3475635-analysts-positive-on-broadcom-symantec-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475632\" data-ts=\"1562154715\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGC\" target=\"_blank\">CGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475632-canopy-growth-down-8-co-ceo-exits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canopy Growth down 8% as co-CEO exits</a></h4><ul> <li>Canopy Growth (NYSE:<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a>) <a href=\"https://seekingalpha.com/pr/17562529-canopy-growth-announces-leadership-transition\" target=\"_blank\">announces</a> that Bruce Linton will step down as co-CEO and Canopy Board member.</li><li>Mark Zekulin has agreed to become the sole CEO.</li><li>Rade Kovacevic will assume the role of President. These changes are effective immediately.</li>                     <li>The Board has also appointed John Bell as its Board Chair. He has served on the board as lead director for 5 years.</li><li>Shares are down <font color=\"red\">8%</font> premarket.</li><li><strong>Update</strong>: In an <a href=\"https://www.cnbc.com/2019/07/03/canopy-growth-co-ceo-to-step-down.html\" target=\"_blank\">interview </a>with CNBC, Mr. Linton says he was fired. The reason for his termination is unclear, just saying that the board and executives needed to be \"reconfigured.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3475632\" data-linked=\"Canopy Growth down 8% as co-CEO exits\" data-tweet=\"$CGC - Canopy Growth down 8% as co-CEO exits https://seekingalpha.com/news/3475632-canopy-growth-down-8-co-ceo-exits?source=tweet\" data-url=\"https://seekingalpha.com/news/3475632-canopy-growth-down-8-co-ceo-exits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475627\" data-ts=\"1562154133\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLRS\" target=\"_blank\">VLRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475627-volaris-reports-22_2-growth-in-june-traffic\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Volaris reports 22.2% growth in June traffic</a></h4><ul> <li>Volaris (NYSE:<a href='https://seekingalpha.com/symbol/VLRS' title='Controladora Vuela Compañía de Aviación, S.A.B. de C.V.'>VLRS</a>) <a href=\"https://seekingalpha.com/pr/17562589-volaris-reports-june-2019-traffic-results-high-load-factors-domestic-91_3-percent\" sasource=\"qp_sum_news_1\" target=\"_blank\">reports</a> revenue passenger miles rose 22.2% to 1.795B in June.</li><li>Domestic RPMs advanced 20.6% Y/Y and international RPMs +25.8% for the month</li><li>Capacity increased 18.9% to 2.01B available seat miles. Domestic ASMs +17.3%; International ASMs +22.3%.</li><li>The number of passengers flown by the carrier during the month grew 24.5% to 1.877M.</li><li>June load factor improved 230 bps to 89.3%.</li><li>YTD load factor up 130 bps to 85.3%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475627\" data-linked=\"Volaris reports 22.2% growth in June traffic\" data-tweet=\"$VLRS - Volaris reports 22.2% growth in June traffic https://seekingalpha.com/news/3475627-volaris-reports-22_2-growth-in-june-traffic?source=tweet\" data-url=\"https://seekingalpha.com/news/3475627-volaris-reports-22_2-growth-in-june-traffic\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475624\" data-ts=\"1562153800\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOR\" target=\"_blank\">MOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475624-morphosys-up-4-premarket-on-22m-milestone-from-glaxo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morphosys up 4% premarket on \u20ac22M milestone from Glaxo</a></h4><ul><li>Morphosys AG (NASDAQ:<a href='https://seekingalpha.com/symbol/MOR' title='MorphoSys AG'>MOR</a>) is up <font color=\"green\">4%</font> premarket on light volume on the heels of the launch of licensee GlaxoSmithKline's <a href=\"https://seekingalpha.com/news/3475618-glaxo-launches-late-stage-development-ra-med-otilimab\" target=\"_blank\">late-stage program</a> for rheumatoid arthritis med otilimab.</li><li>The dosing of the first patient will trigger a \u20ac22M milestone payment from GSK. As a result, MOR is boosting its <a href=\"https://seekingalpha.com/pr/17562601-morphosyss-licensing-partner-gsk-initiates-phase-3-clinical-program-otilimab-mor103\" target=\"_blank\">2019 guidance</a> for revenue to \u20ac65M - 72 from \u20ac43M - 50M and EBIT loss of (\u20ac105M - 115M) from (\u20ac127M - 137M). All other guidance remains as is.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475624\" data-linked=\"Morphosys up 4% premarket on \u20ac22M milestone from Glaxo\" data-tweet=\"$MOR $MPSYF $MPSYY - Morphosys up 4% premarket on \u20ac22M milestone from Glaxo https://seekingalpha.com/news/3475624-morphosys-up-4-premarket-on-22m-milestone-from-glaxo?source=tweet\" data-url=\"https://seekingalpha.com/news/3475624-morphosys-up-4-premarket-on-22m-milestone-from-glaxo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475623\" data-ts=\"1562153793\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISCA\" target=\"_blank\">ISCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475623-international-speedway-eps-misses-0_03-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">International Speedway EPS misses by $0.03, misses on revenue</a></h4><ul><li>International Speedway (NASDAQ:<a href='https://seekingalpha.com/symbol/ISCA' title='International Speedway Corporation'>ISCA</a>): Q2 Non-GAAP EPS of $0.36 <font color=\"red\">misses by $0.03</font>; GAAP EPS of $0.35.</li><li>Revenue of $168.08M (-2.1% Y/Y) <font color=\"red\">misses by $10.91M</font>.</li><li>Shares <font color=\"green\">+1.31%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17562596-international-speedway-corporation-reports-financial-results-second-quarter-fiscal-2019\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3475623\" data-linked=\"International Speedway EPS misses by $0.03, misses on revenue\" data-tweet=\"$ISCA - International Speedway EPS misses by $0.03, misses on revenue https://seekingalpha.com/news/3475623-international-speedway-eps-misses-0_03-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3475623-international-speedway-eps-misses-0_03-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475618\" data-ts=\"1562152741\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSK\" target=\"_blank\">GSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475618-glaxo-launches-late-stage-development-of-ra-med-otilimab\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Glaxo launches late-stage development of RA med otilimab</a></h4><ul><li>GlaxoSmithKline (NYSE:<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline plc'>GSK</a>) <a href=\"https://www.gsk.com/en-gb/media/press-releases/gsk-announces-phase-iii-start-for-its-anti-gm-csf-antibody-otilimab-in-patients-with-rheumatoid-arthritis-ra/\" target=\"_blank\">announces </a>the start of its Phase 3 program evaluating otilimab, an anti-granulocyte macrophage colony-stimulating factor (anti-GM-CSF) monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis &#40;RA&#41; who have failed to respond adequately to disease-modifying antirheumatic drugs (DMARDs) or targeted therapies.</li><li>The program, called ContRAst, will include head-to-head comparisons with current treatments across all studies, including Pfizer's (NYSE:<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a>) XELJANZ (tofacitinib) Regeneron Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a>) and Sanofi's (NASDAQ:<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a>) KEVZARA (sarilumab).</li><li>The primary endpoint for the pivotal trials will be the proportion of patients achieving at least a 20% improvement in RA symptoms (<a href=\"https://eprovide.mapi-trust.org/instruments/american-college-of-rheumatology-20-50-70-criteria\" target=\"_blank\">ACR20</a>).</li><li>GSK owns exclusive global rights to otilimab under a 2013 agreement with MorphoSys AG (NASDAQ:<a href='https://seekingalpha.com/symbol/MOR' title='MorphoSys AG'>MOR</a>).</li><li>Shares are up <font color=\"green\">1%</font> premarket on the <a href=\"https://seekingalpha.com/news/3475604-viivs-hivminus-1-pill-dovato-okd-europe\" target=\"_blank\">European nod</a> for ViiV Healthcare's Dovato for HIV-1 infection.</li></ul><div class=\"tiny-share-widget\" data-id=\"3475618\" data-linked=\"Glaxo launches late-stage development of RA med otilimab\" data-tweet=\"$GSK $PFE $REGN - Glaxo launches late-stage development of RA med otilimab https://seekingalpha.com/news/3475618-glaxo-launches-late-stage-development-of-ra-med-otilimab?source=tweet\" data-url=\"https://seekingalpha.com/news/3475618-glaxo-launches-late-stage-development-of-ra-med-otilimab\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475611\" data-ts=\"1562151983\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMN\" target=\"_blank\">OMN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475611-omnovaplus-50-on-acquisition-synthomer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OMNOVA +50% on acquisition by Synthomer</a></h4><ul> <li>Synthomer plc (<a href='https://seekingalpha.com/symbol/SYHMY' title='Synthomer PLC ADR'>OTC:SYHMY</a>) to acquire OMNOVA Solutions (NYSE:<a href='https://seekingalpha.com/symbol/OMN' title='OMNOVA Solutions Inc.'>OMN</a>) for $10.15 in cash, a premium of 52% over the company's three-month weighted average share price of $6.67.</li><li>The transaction has been approved unanimously by the OMNOVA and Synthomer boards of directors.</li><li>The transaction is not contingent on obtaining financing and is expected to close in late 2019 or early 2020.</li>   <li>OMN  <font color=\"green\">+50.0%</font> premarket to  $9.63</li><li>Source: <a href=\"https://seekingalpha.com/pr/17562434-omnova-acquired-synthomer-plc-london-10_15-per-share-reports-fiscal-2019-second-quarter\" target=\"_blank\">Press Release</a></li><li><a href=\"https://seekingalpha.com/news/3475597-omnova-solutions-eps-misses-0_09-misses-revenue\" target=\"_blank\">Omnova Solutions EPS misses by $0.09, misses on revenue</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3475611\" data-linked=\"OMNOVA +50% on acquisition by Synthomer\" data-tweet=\"$OMN $SYHMY $SYHMY - OMNOVA +50% on acquisition by Synthomer https://seekingalpha.com/news/3475611-omnovaplus-50-on-acquisition-synthomer?source=tweet\" data-url=\"https://seekingalpha.com/news/3475611-omnovaplus-50-on-acquisition-synthomer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3475597\" data-ts=\"1562148131\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMN\" target=\"_blank\">OMN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3475597-omnova-solutions-eps-misses-0_09-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Omnova Solutions EPS misses by $0.09, misses on revenue</a></h4><ul><li>Omnova Solutions (NYSE:<a href='https://seekingalpha.com/symbol/OMN' title='OMNOVA Solutions Inc.'>OMN</a>): Q2 Non-GAAP EPS of $0.12 <font color=\"red\">misses by $0.09</font>; GAAP EPS of $0.12 <font color=\"red\">misses by $0.06</font>.</li><li>Revenue of $205.7M (-0.3% Y/Y) <font color=\"red\">misses by $4.85M</font>.</li><li>Shares <font color=\"green\">+51.87%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17562434-omnova-acquired-synthomer-plc-london-10_15-per-share-reports-fiscal-2019-second-quarter\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3475597\" data-linked=\"Omnova Solutions EPS misses by $0.09, misses on revenue\" data-tweet=\"$OMN - Omnova Solutions EPS misses by $0.09, misses on revenue https://seekingalpha.com/news/3475597-omnova-solutions-eps-misses-0_09-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3475597-omnova-solutions-eps-misses-0_09-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":43,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}